Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Records under this name other than the patents Bontac Bio-Engineering (Shenzhen) Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 4 of 4 · Back to Bontac Bio-Engineering (Shenzhen) Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,950,000 | Use of NADH or salt thereof in preparation of drugs or health-care products for treating phenylketonuria Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,312,948 | Method and enzyme for preparation of enzyme-modified stevia sugar and use of enzyme-modified stevia sugar Lapsed on the fee record Ended Apr 26, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | From the USPTO record |
| US 11,299,721 | Acid phosphatase mutant, use thereof and method for preparing nicotinamide riboside by same Lapsed on the fee record Ended Apr 12, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 12, 2026 | From the USPTO record |
| US 11,052,100 | Stable nicotinamide riboside composition and preparation method thereof Lapsed on the fee record Ended Jul 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2025 | From the USPTO record |